Physician profile

Mark A Noffsinger

Orthopaedic Surgery · Kalamazoo, MI

NPI 1477548428

$142,612.64

in general payments reported to CMS, 2019-2025

7 companies · $9.23 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$620.28
Food and Beverage$102.59

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $59,991.23 2019-2021
Stryker Corporation $54,303.07 2019-2022
Arthrex, INC. $25,592.52 2021-2022
Advanced Orthopaedic Solutions, INC. $1,989.71 2019-2020
Prodigy Surgical Distribution, INC. $705.49 2024
Intuitive Surgical, INC. $17.38 2024-2025
Ferring Pharmaceuticals INC. $13.24 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark A Noffsinger

$142,612.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/339207/mark-a-noffsinger

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.